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ORIGINAL PAPER

Knockdown of heterochromatin protein 1 binding protein 3
recapitulates phenotypic, cellular, and molecular features of
aging
Sarah M. Neuner1,2
1
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2
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Tennessee Health Science Center,
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| Shengyuan Ding1 | Catherine C. Kaczorowski1

Abstract
Identifying genetic factors that modify an individual's susceptibility to cognitive
decline in aging is critical to understanding biological processes involved and mitigating risk associated with a number of age‐related disorders. Recently, heterochro-
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matin protein 1 binding protein 3 (Hp1bp3) was identified as a mediator of cognitive
aging. Here, we provide a mechanistic explanation for these findings and show that
targeted knockdown of Hp1bp3 in the hippocampus by 50%–75% is sufficient to
induce cognitive deficits and transcriptional changes reminiscent of those observed
in aging and Alzheimer's disease brains. Specifically, neuroinflammatory‐related pathways become activated following Hp1bp3 knockdown in combination with a robust
decrease in genes involved in synaptic activity and neuronal function. To test the
hypothesis that Hp1bp3 mediates susceptibility to cognitive deficits via a role in
neuronal excitability, we performed slice electrophysiology demonstrate transcriptional changes after Hp1bp3 knockdown manifest functionally as a reduction in hippocampal neuronal intrinsic excitability and synaptic plasticity. In addition, as
Hp1bp3 is a known mediator of miRNA biogenesis, here we profile the miRNA transcriptome and identify mir‐223 as a putative regulator of a portion of observed
mRNA changes, particularly those that are inflammatory‐related. In summary, work
here identifies Hp1bp3 as a critical mediator of aging‐related changes at the phenotypic, cellular, and molecular level and will help inform the development of therapeutics designed to target either Hp1bp3 or its downstream effectors in order to
promote cognitive longevity.
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1 | INTRODUCTION

including Alzheimer's, it is critical to understand why some individu-

Most individuals will experience some degree of cognitive decline

als are at increased risk for age‐related cognitive decline and even-

during aging, although the extent of this decline can vary widely. As

tual dementia. Studies suggest up to 60%–70% of the variation

aging is the leading risk factor for many neurodegenerative diseases,

observed in cognitive abilities during aging are attributable to genetic
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factors (McClearn et al., 1997), although precise variants involved

De novo gene transcription is a fundamental biological process

have been difficult to identify. Recently, our laboratory identified

underlying LTP and corresponding modification of synapses. Upon

heterochromatin protein 1 binding protein 3 (Hp1bp3) as a modifier

neuronal activation, a highly specific cascade of gene transcription is

of cognitive aging in mice (Neuner et al., 2016). Using a forward

initiated that, under the right conditions, results in stable and long‐

genetics screen in the BXD genetic reference panel, we identified a

lasting functional changes including synaptic localization of ion chan-

quantitative trait locus (QTL) on chromosome 4 which harbored vari-

nels and receptors as well as growth and morphological alterations

ants responsible for variation in cognitive abilities at midlife. Using a

of both axons and dendrites (Gutierrez & Davies, 2011). As with LTP

combination of bioinformatics and functional validation approaches,

itself, multiple lines of evidence support the notion that gene tran-

Hp1bp3 emerged as a likely gene candidate responsible for mediat-

scription is critical for successful memory formation and consolida-

ing the QTL effect. Specifically, strains harboring the DBA2/J (D2)

tion, including studies that have demonstrated amnesic effects

allele of Hp1bp3 exhibited decreased Hp1bp3 gene expression in the

resulting from blocking mRNA synthesis (Da Silva et al., 2008). Mul-

hippocampus in combination with exacerbated cognitive aging. This

tiple classes of genes have been implicated in plasticity‐related tran-

relationship between decreased Hp1bp3 and reduced cognitive func-

scription, including transcription factors such as the cAMP‐response

tion was observed in the Hp1bp3 knockout mouse as well as aging

element‐binding protein (CREB) family and immediate early genes

impaired humans (Neuner et al., 2016). However, the mechanistic

such as the activity‐regulated cytoskeleton‐associated protein (Arc)

link between Hp1bp3 and regulation of cognitive function remains to

and c‐Fos (Alberini & Kandel, 2014).

be elucidated. Therefore, the goal of this study was to better under-

However, it remains to be elucidated exactly how these tran-

stand how Hp1bp3 influences cognitive function under baseline con-

scriptional programs are activated and how variation in de novo

ditions in adult animals by using virally encoded shRNA targeting

gene transcription under baseline conditions may contribute to cog-

Hp1bp3 designed to reduce expression similar to that observed in

nitive impairment. The precise nature of activity‐related gene tran-

aging impaired individuals.

scription implicates modification of chromatin structure as critical for

Hp1bp3 is a heterochromatin binding protein that is related to
the histone H1 family of proteins (Garfinkel, Melamed‐Book, Anuka,

memory formation and consolidation, as specific genes need to be
accessible by transcriptional machinery at defined intervals.

Bustin, & Orly, 2015). It has been implicated in a variety of func-

Here, we assess the effects of a hippocampus‐specific knock-

tions, most notably selective regulation of gene expression via a role

down (KD) of Hp1bp3 on cognitive function, the hippocampal tran-

in the modulation of chromatin structure (Dutta et al., 2014) and

scriptome, neuronal excitability, and synaptic plasticity. We perform

micro‐RNA (miRNA) biogenesis in human cells (Liu et al., 2016). In

these experiments in both the C57BL6/J (B6) and D2 inbred mouse

our previous study, enrichment analysis of the hippocampal tran-

strains to enhance the rigor of our approach, as recent findings sug-

scriptome in relation to Hp1bp3 identified negative correlates of

gest studies conducted in a single genetic background limit the gen-

Hp1bp3 significantly enriched for localization to the plasma mem-

eralizability of mouse studies (Sittig et al., 2016). We chose these

brane, with functional annotations including ion channel activity and

two strains as they are the parental lines of the BXD genetic refer-

G‐protein coupled receptor activity (Neuner et al., 2016). Plasma

ence panel that was originally used to discover Hp1bp3 as a modifier

membrane ion channels and receptors are critical regulators of neu-

of cognitive aging (Neuner et al., 2016; Peirce, Lu, Gu, Silver, & Wil-

ronal excitability and synaptic plasticity, leading candidate mecha-

liams, 2004). In addition, the B6 and D2 strains show marked pheno-

nisms for memory storage (Kandel, 2001). Taken together, this

type differences in a variety of domains, including both cognitive

information led us to hypothesize that Hp1bp3 may be mediating its

function and hippocampal neuronal excitability (Matsuyama, Nam-

effects on cognitive longevity via the modulation of hippocampal

gung, & Routtenberg, 1997; Nguyen, Abel, Kandel, & Bourtchou-

neuronal excitability.

ladze, 2000; Philip et al., 2010). It was our hypothesis that any

Synaptic plasticity mechanisms such as long‐term potentiation
(LTP) have been identified as leading molecular and cellular mecha-

effect of Hp1bp3 KD observed across strains would be robust and
potentially translatable to diverse genetic contexts.

nisms of memory storage based on their properties of that include
input specificity and associativity (Bliss & Collingridge, 1993). Intrinsic neuronal excitability is intimately linked to these processes, as
changes in the intrinsic excitability of a neuron will influence its ability to respond to input—ultimately influencing synaptic throughput
and the ability of a neural network to undergo long‐lasting changes

2 | RESULTS
2.1 | Hippocampus‐specific knockdown of Hp1bp3
impairs cognitive function

such as LTP (Zhang & Linden, 2003). Multiple lines of evidence sup-

In order to test the hypothesis that Hp1bp3 modifies cognitive func-

port the contention that these mechanisms are critical for learning

tion through a hippocampus‐specific effect rather than a peripheral

and memory. For example, aged cognitively impaired rodents exhibit

effect (Garfinkel, Arad, et al., 2015), we designed an adeno‐associ-

significantly decreased intrinsic neuronal excitability relative to

ated virus serotype 9 (AAV9) viral vector encoding either shRNA for

young or nonimpaired controls (Kaczorowski & Disterhoft, 2009),

Hp1bp3 or a scrambled (scrmb) control and delivered 1.0 µl bilater-

and pharmacological agents that block LTP have also been observed

ally to the dorsal hippocampus of adult (3–6 months) B6 and D2

to impair cognitive function (Abraham & Mason, 1988).

mice (Figure 1a). Efficacy of the viral vector to reduce HP1BP3
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levels was confirmed via western blot (Figure 1b). Notably, no reduc-

significant overlap with a list of genes most highly expressed by

tion in HP1BP3 levels was observed in the cortex or cerebellum,

microglia (hypergeometric test p < 0.001, Figure 2d). In contrast,

indicating minimal viral spread outside our target region (Supporting

among genes downregulated by Hp1bp3 KD, we identified a signifi-

Information Figure S1). Four to six weeks following injection, we

cant enrichment for a number of terms related to neuron structure

assessed both working and long‐term contextual fear memory in

and function, including regulation of neuronal synaptic plasticity,

these mice. There was a significant effect of Hp1bp3 KD on working

excitatory synapse, and various channel activity terms (Figure 2e). In

memory as measured in the T‐maze, with both B6 and D2 mice

addition, among genes downregulated by Hp1bp3 KD, there was a

receiving AAV9‐shRNA‐Hp1bp3 performing worse than their control

significant enrichment for transcripts experimentally observed to be

counterparts [Figure 1b, two‐way ANOVA, effect of treatment F(1,

most highly expressed in neurons and myelinating oligodendrocytes

41) = 5.9, p = 0.02]. Long‐term contextual fear memory was then

(hypergeometric test, p < 0.001).

assessed via contextual fear conditioning. Although D2 mice overall

As synaptic plasticity is a leading candidate mechanism for infor-

performed more poorly than B6 mice during training, there was no

mation and memory storage, and due to the fact that we identified

effect of Hp1bp3 KD on contextual fear acquisition as measured by

regulation of ion channels and receptors as a candidate mechanism

freezing during the 40 s following the final shock [Figure 1c, left,

for Hp1bp3‐induced cognitive impairment in an aging mouse popula-

two‐way ANOVA, effect of strain F(1, 39) = 5.4, p = 0.03, effect of

tion (Neuner et al., 2016), we were particularly interested in the

treatment F(1, 39) = 0.12, p = 0.73]. In contrast, there was a signifi-

most significantly downregulated GO term, regulation of neuronal

cant main effect of treatment on contextual fear memory [Figure 1c,

synaptic plasticity. The identification of this pathway was driven by

right, two‐way ANOVA, effect of strain F(1, 39) = 56.4, p < 0.001,

19 genes strongly downregulated by Hp1bp3 KD (normalized enrich-

effect of treatment, F(1, 39) = 13.6, p = 0.001], suggesting Hp1bp3 is

ment score = −2.2, FDR = 0.01, Figure 3a). Of these 19 genes, 14

uniquely involved in mechanisms underlying memory consolidation

were identified as core driver genes by GSEA. Notably, the core dri-

and/or recall, but not fear acquisition. This effect was driven by the

ver gene most significantly downregulated by treatment, particularly

B6 strain, as the D2 mice performed so poorly no additional effect

in B6 mice, was the activity‐regulated cytoskeleton‐associated pro-

of treatment was observed, as evidenced by a significant interaction

tein (Arc), a gene repeatedly implicated in learning and memory but

between strain and treatment [interaction between strain and treat-

for whom the upstream regulators remain poorly defined [(Shepherd

ment F(1, 39) = 14.5, p < 0.001]. These effects were not due to

& Bear, 2011), Figure 3b]. Additional core driver genes included a

nonspecific effects on anxiety, activity, or overall growth as mea-

number of ion channels and receptors, including: (a) shisa family

sured by open‐arm entries on the elevated plus maze, total arm

member 9 (Shisa9), an AMPAR auxiliary subunit (von Engelhardt

entries, speed, and weight, respectively (Supporting Information Fig-

et al., 2010), (b) junctophilin 3 (Jph3), a transmembrane junctional

ure S2).

protein implicated in the regulation of the slow after‐hyperpolarization (Moriguchi et al., 2006), (c) brevican (Bcan), an extracellular

2.2 | Hp1bp3 knockdown alters specific aspects of
the hippocampal transcriptome
We next wanted to determine the mechanism(s) by which hippocam-

matrix protein that regulates the speed of synaptic transmission
(Blosa et al., 2015), and (d) disks large homolog 4 (Dlg4), also known
as postsynaptic density protein 96 (Psd95), which plays a critical role
in organizing postsynaptic signaling (Chen et al., 2011).

pal KD of Hp1bp3 may be impairing cognitive function. We performed total RNA sequencing on whole hippocampal lysates from
three mice per strain/treatment group and confirmed knockdown of
Hp1bp3 at the mRNA level (Figure 2a). A subset of genes were identified to as differentially expressed relative to both strain background

2.3 | Hp1bp3 knockdown decreases intrinsic
excitability and synaptic plasticity of hippocampal
neurons

and treatment group, while relatively few genes displayed a signifi-

To directly test the validity of the findings that Hp1bp3 KD alters

cant strain by treatment interaction, suggesting Hp1bp3 KD alters

neuronal excitability and synaptic plasticity, we performed slice elec-

the hippocampal transcriptome comparably across background strain

trophysiology to measure the properties of neurons from either

(Figure 2b and Supporting Information Table S1). To identify specific

mice receiving AAV9‐shRNA‐Hp1bp3 or AAV9‐scrmb‐shRNA. Specif-

pathways and functional categories altered by Hp1bp3 KD, we next

ically, mice were sacrificed at least 6 weeks following viral injection

utilized gene set enrichment analysis (GSEA) in order to identify

and brains quickly removed, sectioned, and maintained in aCSF for

gene ontology (GO) terms significantly enriched among differentially

recordings. For the subset of mice that were behaviorally tested,

expressed genes. Among genes upregulated by Hp1bp3 KD, we iden-

slice electrophysiology occurred at least two weeks after the conclu-

tified a significant enrichment for immune‐related terms, including

sion of behavioral testing to allow hippocampal neurons to return to

response to interferon gamma, chemokine‐mediated signaling, and

baseline conditions. We first examined intrinsic neuronal properties

response to type I interferon (Figure 2c). This increase in inflamma-

and found Hp1bp3 KD significantly increased the slow after‐

tory signaling seemed to be driven largely by an increase in micro-

hyperpolarization (sAHP) of hippocampal pyramidal neurons [Fig-

glia, as genes upregulated by Hp1bp3 KD that also display a

ure 4, two‐way ANOVA, effect of treatment F(1,56) = 6.7, p = 0.01,

significant cell type‐specific expression (Zhang et al., 2014) showed a

no main effect of strain]. This seemed to be a relatively specific
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F I G U R E 1 Hippocampus‐specific knockdown of Hp1bp3 impairs cognitive function. (a) 1.0 μl of AAV9 encoding either Hp1bp3 shRNA or a
scrambled control was injected bilaterally into the dorsal hippocampus of adult C57BL/6 J (B6) and DBA/2 J (D2) mice. After 4–6 weeks, a
subset of mice were behaviorally tested. A minimum of two weeks later, mice were either harvested or used for electrophysiology. Mouse
brain image adapted from The Mouse Brain in Stereotaxic Coordinates (Paxinos and Franklin, 2013). (b) Left, efficacy of the viral vector to
reduce HP1BP3 levels in the hippocampus was confirmed via western blot; n = 6/group, two‐way ANOVA effect of strain F(1, 20) = 1.2
p = 0.3, effect of treatment F(1, 20) = 15.6, p = 0.001, no interaction. Right, data from four independent blots (two experiments) were pooled
across strains (n = 12/group) and quantified. Lysate from human 293 T cells overexpressing HP1BP3 was used as a positive control. (c)
Working memory was measured in the T‐maze. A significant effect of treatment was observed F(1, 41) = 5.9, p = 0.02, indicating that Hp1bp3
KD impairs working memory function across B6 and D2 mice. (d) Long‐term memory was assessed using contextual fear conditioning.
Although B6 and D2 mice acquired the task differently on Day 1 [effect of strain, F(1, 39) = 5.4, p = 0.03], Hp1bp3 KD had no effect on the
extent of these differences [effect of treatment, F(1, 39) = 0.12, p = 0.73]. Right, when mice were placed back in the training chamber on Day
2, D2 mice performed significantly worse than B6 mice [effect of strain F(1, 39) = 56.4, p < 0.001]—so poorly that further impairment caused
by Hp1bp3 reduction could not be observed. However, Hp1bp3 KD did impair contextual fear memory in B6 mice [effect of treatment, F(1,
39) = 13.6, p = 0.001, interaction between strain and treatment F(1, 39) = 14.5, p < 0.001]. *main effect of treatment, p < 0.05, **t test,
p < 0.05

effect, as resting properties such as resting membrane potential and

In a separate cohort of mice, we next assessed the role of

input resistance of the cell were not altered by knockdown,

Hp1bp3 in synaptic plasticity by placing a stimulating electrode in

although strain‐specific differences were observed (Supporting Infor-

the Shaffer collateral pathway and eliciting excitatory postsynaptic

mation Figure S3). In addition, Hp1bp3 KD did not change the

potentials (EPSPs) in CA1, measured via whole‐cell recordings (Fig-

intrinsic firing properties of the neurons, as measured by threshold

ure 4c). Stimulation was titrated so that EPSPs 5 mV in amplitude

required to fire an action potential and the peak after‐hyperpolariza-

were elicited once every 20 s for 5 min to obtain a stable baseline

tion (Table 1).

EPSP measurement. Theta‐burst stimulation (TBS), a paradigm shown

|
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F I G U R E 2 Knockdown of Hp1bp3
alters specific aspects of the hippocampal
transcriptome. (a) Knockdown of Hp1bp3
was confirmed at the mRNA level [two‐
way ANOVA, effect of strain F(1, 8) = 2.6,
p = 0.02, effect of treatment F(1,8) = 17.1,
p = 0.003, no interaction between strain
and treatment]. *main effect of treatment,
p < 0.05. (b) Hp1bp3 knockdown largely
effects B6 and D2 mice similarly. Effect of
strain: Upregulated genes are more highly
expressed in B6 hippocampus. Effect of
treatment: Upregulated genes are more
highly expressed in Hp1bp3 KD
hippocampus. (c) Among genes upregulated
by Hp1bp3 KD that display a cell type
specificity in their expression, there was a
significant enrichment for immune‐related
gene ontology (GO) terms. (d) There was a
significant overlap between genes
upregulated by Hp1bp3 KD and genes
most highly expressed in endothelial cells
(EC) and microglia (hypergeometric test,
p < 0.001). *, p < 0.05. (e) Among genes
downregulated by Hp1bp3 KD, there was a
significant enrichment for terms related to
neuronal excitability, structure, and
function. (f) There was a significant overlap
between genes downregulated by Hp1bp3
KD that also display a cell type specificity
in their expression and genes most highly
expressed in neurons and myelinating
oligodendrocytes (hypergeometric test,
p < 0.001). *, p < 0.05

(b)

*

N

NEUNER

to elicit long‐term potentiation in the Shaffer collateral (Graves,

Information Figure S4c). In summary, these data demonstrate

Moore, Spruston, Tryba, & Kaczorowski, 2016), was delivered imme-

Hp1bp3 specifically regulates neuronal excitability and plasticity nec-

diately following five minutes of baseline recording. EPSPs continued

essary for successful cognitive performance on both working and

to be elicited once every 20 s for 35 min to measure the change in

contextual fear memory tasks.

EPSP amplitude post‐TBS. Data were collected and pooled into 5‐
min bins for further analysis (Figure 4d). Mice receiving AAV9‐
Hp1bp3‐shRNA displayed significantly impaired LTP relative to mice
receiving AAV9‐scrmb‐shRNA, particularly at late time points [Fig-

2.4 | Hp1bp3 selectively regulates a subset of
micro‐RNAs

ure 4e‐H]. No significant effects of strain, or interaction between

Recent studies have demonstrated that HP1BP3 plays a role in

time and strain, were observed, indicating that Hp1bp3 KD impaired

miRNA biogenesis in human cells in vitro (Liu et al., 2016). To inves-

synaptic plasticity similarly across groups. Notably, Hp1bp3 KD did

tigate whether observed transcriptional changes were due to a global

not impair baseline characteristics such as intrinsic excitability as

change in miRNA biogenesis, we analyzed the small RNA sequences

measured by the number of action potentials fired in response to a

generated by our initial total RNA sequencing on hippocampal tissue

1‐s sustained current injection (Supporting Information Figure S4a),

from 3 mice/group. Of 1915 miRNAs identified and tested for differ-

amplitude of EPSPs in response to increasing stimulation intensities

ential expression analysis, only 35 showed differential expression rel-

(Supporting Information Figure S4b), or paired pulse ratio (Supporting

ative to treatment at an adjusted p‐value of 0.10 (Figure 5a and
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D2

Strain

25,000

22,500

20,000

17,500
B6

D2

Strain

F I G U R E 3 Hp1bp3 KD negatively
regulates neuronal synaptic plasticity. (a)
Enrichment plot illustrating enrichment of
the GO term regulation of neuronal
synaptic plasticity among genes
downregulated by Hp1bp3 KD. Enrichment
score = −0.6, Normalized enrichment
score = −2.2, FDR = 0.01. (b) The core
driver gene most significantly
downregulated by Hp1bp3 KD, particularly
in B6 mice, was Arc (DESeq2 effect of
treatment; log2FC = −1.2, adjusted
p = 0.001, effect of strain; log2FC = −1.2,
adjusted p = 0.001, interaction adjusted
p = 0.2). (c) A number of plasma membrane
proteins, particularly ion channels and
receptors, were identified as additional
core drivers of this enrichment. *DESeq2
main effect of treatment, p < 0.05

Supporting Information Table S2), with only 9 remaining significant

was activated in our dataset, and indeed, mir‐223 (specifically mmu‐

at an adjusted p = 0.05. Thus, <0.5% of all miRNAs tested exhibit

mir‐223‐3p) was observed to be upregulated after Hp1bp3 KD (two‐

significant differential expression following Hp1bp3 KD. This is in

way ANOVA, effect of treatment F(1, 8) = 5.6, p = 0.046, Figure 5b)

comparison with mRNA, where just over 7% of all mRNAs tested

and was one of the miRNA transcripts identified as significantly dif-

were differentially expressed relative to Hp1bp3 KD (proportions of

ferentially expressed by DESeq2 at an adjusted p = 0.10 (mmu‐mir‐

differentially

different, Z = 11.5,

223‐3p adjusted p = 0.09, log2FC = 1.2). mir‐223, best studied in

p < 0.001), suggesting Hp1bp3 plays a much broader role in the reg-

the context of hematopoietic stem cells, has been shown to function

ulation of mRNA expression over miRNA expression. These results

as a key modulator in the differentiation and activation of myeloid

demonstrate that in contrast to what has been observed in human

cells and has been implicated in a number of immune system func-

cells, Hp1bp3 does not seem to be a global regulator of miRNA bio-

tions (Yuan et al., 2018). In accordance with these known functions,

genesis in vivo in the mouse hippocampus.

the list of mir‐223 targets differentially expressed after Hp1bp3 KD

expressed

genes significantly

Although global changes in miRNA expression were not

was identified to be most highly enriched for the GO Biological Pro-

observed, we next tested the hypothesis that the select miRNAs reg-

cess term “immune system process” (FDR < 0.001) through Web-

ulated by Hp1bp3 may explain downstream observed changes in

Gestalt over‐representation enrichment analysis (Wang, Duncan, Shi,

mRNA expression and synaptic function. First, we input the list of

& Zhang, 2013). Notably, mir‐223 has been shown to promote matu-

mRNAs differentially expressed relative to treatment into Ingenuity

ration, proliferation, and activation of myeloid cells (Tsitsiou & Lind-

Pathway Analysis (IPA) software (Kramer, Green, Pollard, & Tugen-

say, 2009), which overlaps with our previous observation that the

dreich, 2014) and used the Core Analysis function to identify puta-

upregulation of immune‐related genes following Hp1bp3 KD is likely

tive miRNA upstream regulators of our observed mRNA changes

due to an increase in numbers of microglia (Figure 2d).

(Supporting Information Table S3). A number of miRNAs were identified as putative upstream regulators, as measured by significant
overlap of known target genes and genes present in our list of differentially expressed mRNA. The top predicted upstream regulator,
mir‐21, was predicted to be inhibited in our dataset based on the

2.5 | Transcriptome‐level changes induced by
Hp1bp3 knockdown recapitulate those observed in
human aging

direction of change in its target molecules. However, the pattern of

In addition to standard GO terms and functional pathways, GSEA

mir‐21 differential expression after Hp1bp3 KD did not fit this pat-

also allows gene lists of interest to be compared against experimen-

tern, eliminating mir‐21 as a miRNA that could possible explain

tally derived gene sets that have been uploaded into the Molecular

mRNA changes observed in our hands (Supporting Information

Signatures Database (Liberzon et al., 2011). When we compared our

Table S3). Next, we examined the miRNA identified as the second

list of differentially expressed mRNAs to the chemical and genetic

most likely miRNA upstream regulator, mir‐223. Based on the direc-

perturbations (CPG) database, we observed significant overlap

tion of change of its target molecules, IPA predicted that mir‐223

between genes downregulated by Hp1bp3 KD and those genes
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F I G U R E 4 Hp1bp3 KD decreases intrinsic neuronal excitability and synaptic plasticity. (a) 25 action potentials were trigged by somatic
current injection, and the slow after‐hyperpolarization was recorded 1 s after the last stimulus offset. sAHPs were not different across B6 and
D2 mice [effect of strain, F(1,56) = 0.1, p = 0.7] so data presented are pooled across strains. A significant effect of treatment was detected [F
(1, 56) = 6.7, p = 0.01], indicating that across strains, Hp1bp3 increases the sAHP. (b) Representative traces from Ctrl and KD animals. (c)
Diagram of recording configuration for synaptic experiments. A stimulating electrode was placed in the Shaffer collateral leading from CA3 to
CA1. Single neurons were recorded from in CA1 using whole‐cell patch‐clamp electrophysiology. (d) Excitatory postsynaptic potentials (EPSPs)
were evoked once every 20 s for five minutes to obtain a stable baseline measure (BL). Theta‐burst stimulation (TBS) was delivered and EPSPs
continued to be evoked and measured every 20 s for 35 min. Data were pooled into five‐minute bins for further analysis. A significant within‐
subjects effect of time was observed [two‐way repeated measures ANOVA, Greenhouse‐Geisser corrected results, F(2, 155) = 18.3,
p < 0.001], as EPSP amplitude increased drastically after TBS. A significant within‐subjects interaction between time and treatment was
observed [F(2, 185) = 4.2, p = 0.01], and further posthoc testing indicated that control and Hp1bp3 KD groups were significantly different at
the two latest time points tested (*p < 0.05). No interaction between time and strain was observed [F(2, 185) = 1.0, p = 0.4], indicating that
Hp1bp3 knockdown impaired LTP similarly across strains. (e) Representative traces from B6 Ctrl, (f) B6 KD, (g) D2 Ctrl, and (h) D2 KD animals
both pre‐ and post‐TBS
downregulated with age in the human frontal cortex [(Lu et al.,

aging human frontal cortex and the mouse hippocampus following

2004), FDR q‐value = 0.04, Figure 6a]. This significant enrichment

Hp1bp3 KD, 37 of which were determined by GSEA to be core dri-

was driven by 43 genes significantly downregulated in both the

vers of enrichment. The twenty most significantly downregulated
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recapitulate cognitive deficits observed previously in global Hp1bp3

AHPpeak
(mV)

knockout mice (Neuner et al., 2016).

Group

RMP (mV)

IR (MΩ)

APthreshold
(mV)

B6 Ctrl

−64.3 ± 0.5

154.8 ± 8.7

−50.0 ± 0.7

−4.2 ± 0.6

tial working memory and contextual fear memory, but not in contex-

B6 KD

−64.0 ± 0.5

135.0 ± 10.0

−50.5 ± 1.0

−4.2 ± 0.5

tual fear acquisition. This implicates a relatively specific role for

D2
Ctrl

−62.3 ± 0.5

192.9 ± 15.6

−48.6 ± 0.6

−5.1 ± 0.6

Hp1bp3 in mechanisms underlying working memory as well as mem-

D2 KD

−61.3 ± 0.2

Specifically, in both cases, we observed impairments in both spa-

ory consolidation and recall, but highlights that contextual fear
188.8 ± 0.9

−48.9 ± 0.8

acquisition may rely on independent mechanisms for successful com-

−4.6 ± 0.5

pletion. Overall, results here demonstrate that cognitive deficits

Note. AHP: after hyperpolarization; AP: action potential; Ctrl: control; IR:
input resistance; KD: knockdown; mV: millivolts; MΩ: megaohms; RMP:
resting membrane potential.

caused by Hp1bp3 deficiency, presumably in both KO mice and aged
impaired mice, are due primarily to Hp1bp3 deficiency in the hippocampus. This is an important finding, as Hp1bp3 knockout mice

core drivers, as well as their corresponding fold changes from the

are smaller than WT littermates and have alterations in insulin signal-

human brain (Lu et al., 2004), are listed in Figure 6b. As a group, this

ing that may have impacted cognitive performance due to peripheral

set of commonly downregulated genes displayed relatively diverse

mechanisms (Garfinkel, Arad, et al., 2015). In addition, we extend our

enrichment for GO Biological Process terms using WebGestalt over‐

previous finding that loss of Hp1bp3 has a negative impact in cogni-

representation enrichment analysis (Wang et al., 2013), including

tive function and provide mechanistic insight into how these alter-

interleukin secretion (IL‐5 FDR = 0.03, IL‐13 FDR = 0.03), micro-

ations occur. Specifically, we show Hp1bp3 KD negatively regulates

tubule polymerization (FDR = 0.04), and chemical synaptic transmis-

a number of genes critical for synaptic plasticity and neuronal activ-

sion (FDR = 0.04), all processes known to be altered in aging.

ity, including the immediate early gene Arc (Figure 2b). Although Arc

Combined with our previous observation that HP1BP3 expression is

is well‐known to be critical for memory formation (Guzowski et al.,

decreased in cognitively impaired aging humans, the overlap of the

2000; Plath et al., 2006), the precise signaling cascades involved in

broader Hp1bp3 KD transcriptome with that of human aging sup-

Arc transcription and regulation are not well‐defined (Shepherd &

ports the idea that Hp1bp3 is a critical regulator of a number of the

Bear, 2011).

transcriptional changes that occur during aging and may serve as a

Here, we discover a novel role for Hp1bp3 as a regulator of Arc

valuable therapeutic target to delay or prevent aging‐related cogni-

expression, which implicates Hp1bp3 in the broader context as a

tive decline.

master regulator of transcriptional network changes required for successful induction of synaptic plasticity, likely via its role in modifying
chromatin structure (Dutta et al., 2014). Finally, we demonstrate that

3 | DISCUSSION

observed transcriptional changes functionally manifest as impair-

3.1 | Hippocampal Hp1bp3 regulates cognitive
function, gene transcription, and synaptic plasticity

ments in both intrinsic neuronal excitability and synaptic plasticity.

Here, we demonstrate for the first time that a targeted knockdown

result, we can now better understand how misregulation of Hp1bp3

of Hp1bp3 in the hippocampus by 50%–75% was sufficient to

may contribute to cognitive impairments seen in both Hp1bp3

Together, these results provide important insight into physiological
functions of Hp1bp3 under baseline conditions in adult mice. As a

(b)
mmu.miR.223.3p (log Counts)

(a)

Log FoldChange

4
2
0
–2
–4
0.1

10

100

100,000

Mean normalized counts

*
Ctrl

8.0

KD
7.5

7.0

6.5
B6

D2

Strain

F I G U R E 5 Hp1bp3 selectively regulates the miRNA transcriptome in vivo. (a) Plot illustrating (x‐axis) average miRNA expression versus (y‐
axis) log fold change as measured by DESeq2. Red dots illustrate those miRNA transcripts that were determined to be differentially expressed
relative to treated at an adjusted p = 0.10. (b) miRNA mmu‐mir‐223‐3p was identified as a putative upstream regulator of observed mRNA
changes after Hp1bp3 KD and was predicted to be activated in our dataset by IPA. mmu‐mir‐223‐3p was significantly upregulated by Hp1bp3
knockdown [*two‐way ANOVA, effect of treatment F(1, 8) = 5.6, p = 0.046, no significant effect of strain or interaction between strain and
treatment]
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F I G U R E 6 Transcriptome‐level changes
induced by Hp1bp3 knockdown
recapitulate those observed in human
aging. (a) Enrichment plot illustrating
overlap of genes downregulated in the
human aging cortex with genes among
genes downregulated by Hp1bp3 KD.
Enrichment score = −0.4, Normalized
enrichment score = −1.9, FDR = 0.04. (b)
List of twenty genes downregulated by
Hp1bp3 KD and their corresponding fold
changes in the human aging cortex as
reported by Lu et al. (2004)

Enrichment Score (ES)

(a)

(b)

Overlap with genes downregulated
in Human Aging
0.05
0.00
–0.05
–0.10
–0.15
–0.20
–0.25
–0.30
–0.35
–0.40

FDR q-value: 0.04

upregulated genes

knockout mice and cognitively impaired aging mice and humans with
decreased levels of Hp1bp3 (Neuner et al., 2016).

downregulated genes

Current Study
Gene
Log2FC
Gabrd
–0.88
Kcnj9
–0.77
Itpka
–0.62
Rasgrf1 –0.58
Smarca2 –0.57
Sst
–0.54
Camk2a –0.47
Cap2
–0.44
Scn2b
–0.44
Map1b
–0.42
Inpp4a
–0.41
Camk4
–0.41
Prkcg
–0.41
Prkcz
–0.36
Mapt
–0.36
Atp6v1g2 –0.35
Rab3a
–0.35
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Lu et al. (2004)
Accession
AF016917
U52152
X54938
S62035
D26155
AI636761
AB023185
HG2530-HT2626
AF049498
L06237
AI955897
D30742
Z15114
Z15108
J03778
W26326
M28210

FC
–1.54
–2.22
–2.46
–4.04
–1.79
–2.87
–1.74
–2.34
–5.09
–4.39
–1.97
–1.98
–1.77
–1.66
–2.31
–1.51
–1.74

3.3 | Hp1bp3 as a regulator of miRNA biogenesis
Contrary to previous reports (Liu et al., 2016), Hp1bp3 does not

3.2 | Hp1bp3 effect on cognition and neural
function is robust to genetic context

seem to be a global regulator of miRNA biogenesis, at least in the

It has long been known that genetic background is critical for modi-

human), differences in experimental techniques (in vitro vs. in vivo),

fying phenotypic presentation. Recently, this was highlighted by a

and even differences in miRNA alignment protocols. In addition, we

survey of 30 inbred lines, where in some cases, opposite conclusions

did observe a select set of miRNAs differentially expressed relative

were drawn regarding the effect of gene knockout depending on the

to Hp1bp3 KD, suggesting Hp1bp3 does regulate biogenesis of at

genetic context of the manipulation (Sittig et al., 2016). Therefore,

least some miRNAs in vivo. Of particular interest to this study is

adult mouse hippocampus. Multiple explanations for these conflicting
results exist, including different experimental species (mouse vs.

we thought it important to evaluate the effect of Hp1bp3 manipula-

mir‐223, which was identified by IPA as a putative upstream regula-

tion in more than one genetic background. We performed our exper-

tor of observed mRNA‐level changes following Hp1bp3 KD and

iments in the B6 and D2 inbred strains, as these strains were used

whose expression in our miRNA sequencing data changed concor-

to derive the BXD genetic reference panel which was originally used

dantly with that predicted by IPA. As a number of immune‐related

for identifying Hp1bp3 as a modifier of cognitive aging. These two

genes have been shown to be downregulated in mir‐223 deficient

strains show marked differences in learning and memory abilities

cells (Lu et al., 2013), the large number of immune‐related genes

(Neuner et al., 2016; Philip et al., 2010) as well as differences in cer-

upregulated after Hp1bp3 KD may, in part, be due to observed

tain types of LTP (Matsuyama et al., 1997; Nguyen et al., 2000). In

upregulation of mmu‐mir‐223‐3p. While mir‐223 is best studied in

general, our data are consistent with this literature, with the B6

the context of the hematopoietic system, recent studies have inves-

strain outperforming the D2 strain on contextual fear conditioning.

tigated its role in CNS functions and it has recently been shown to

While we demonstrate here TBS is capable of inducing LTP in both

be enriched in the hippocampus relative to other brain regions (Har-

strains, other types of LTP have been shown to be reduced in the

raz, Eacker, Wang, Dawson, & Dawson, 2012). In particular, mir‐

D2 strain (Schimanski & Nguyen, 2005), which may explain their

223 has been shown to decrease total dendritic tree length, branch

poor performance on contextual fear conditioning—a task which

number, and complexity in cell culture (Harraz, Xu, Guiberson, Daw-

requires synaptic plasticity (Tang et al., 1999). Poor performance on

son, & Dawson, 2014) and specifically target glutamate receptor

contextual fear conditioning may also be explained, in part, by lower

transcripts for degradation in vivo (Harraz et al., 2012), which may

baseline levels of Hp1bp3 mRNA observed in the D2 strain (Fig-

link mir‐223 to some of the additional neuronal phenotypes

ure 2a), which while not detected at the protein level (Figure 1b), is

observed in Hp1bp3 KD mice. In summary, while miRNA biogenesis

consistent with our previous findings that BXD strains carrying the

likely contributes to some of the transcriptional changes observed

D allele of Hp1bp3 show decrease hippocampal Hp1bp3 expression.

after Hp1bp3 KD, additional mechanisms regulating gene expression

As Hp1pb3 knockdown impaired cognitive function and reduced

are likely at play, including alterations in chromatin structure that

neuronal excitability in both strains, as well as largely affected the

result in changes in the accessibility of key genomic regions to nec-

transcriptome across strains similarly (Figure 2b), our data suggest

essary transcriptional machinery.

Hp1bp3 deficiency has a robust detrimental effect on cognitive function regardless of genetic context. This broadens the translational
relevance of this finding, as restoring Hp1bp3 levels (or supplementing with a small molecule that increases Hp1bp3 levels [e.g., Met-

3.4 | Hp1pb3 knockdown recapitulates symptoms
of aging and Alzheimer's disease

formin (Neuner et al., 2016)]), is likely to be beneficial to a wider

Many alterations observed after Hp1bp3 KD appear to phenocopy

variety of subjects than a target with context‐dependent effects.

alterations observed in aging and Alzheimer's disease (AD). In
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particular, studies have identified decreases in neuronal excitability

therapeutics designed to target either Hp1bp3 or its downstream

as cellular correlates of cognitive impairments in aging animals (Dis-

effectors (such as those plasma membrane ion channels and recep-

terhoft, Wu, & Ohno, 2004). Notably, the sAHP is increased in aged

tors highlighted in Figure 3c) in order to help promote cognitive

impaired animals relative to young and aged nonimpaired animals

longevity and reduce the risk of multiple age‐related diseases.

(Kaczorowski & Disterhoft, 2009). Similar neuronal phenotypes have
been observed in animal models of AD (Kaczorowski, Sametsky,
Shah, Vassar, & Disterhoft, 2011). As these aged and AD neurons
are less able to respond adequately to input, this reduced neuronal
excitability translates into a reduction in the maintenance of LTP and
poorer memory storage. Transcriptionally, mRNA changes after
Hp1bp3 KD significantly overlap mRNA changes observed in the
aging human cortex [FDR < 0.05, Figure 6, (Lu et al., 2004)] and are
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